VANDA PHARMACEUTICALS INC (VNDA)

US9216591084 - Common Stock

4.48  -0.12 (-2.61%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
190.86M192.64M254.40M268.70M248.20M
Cost Of Goods
12.18M14.80M24.30M25.60M23.40M
Gross Profit
178.67M177.84M230.10M243.10M224.80M
Operating Expenses
216.15M191.80M223.80M181.10M190.60M
Research and Development
78.93M76.82M85.80M55.60M48.70M
Selling, General, and Administrative Expenses
130.75M112.88M136.50M124.00M140.50M
Operating Income
-37.48M-13.95M6.30M62.00M34.10M
Other Income/Expense
19.39M20.29M5.00M200.00K4.40M
Non Recurring Items
N/AN/AN/A-19.80M-6.90M
Income Before Taxes
-18.09M6.34M11.30M42.40M31.70M
Income Tax
-1.70M3.83M5.00M9.20M8.30M
Net Income
-16.39M2.51M6.30M33.20M23.30M
EBITDA
-30.11M-10.94M9.00M64.90M37.00M
 
Per Share Data
EPS Diluted Total Ops
-0.280.040.110.580.42
Non GAAP EPS
-0.280.050.120.580.43
 
Statistics
Gross Profit Margin
93.62%92.32%90.45%90.47%90.57%
Profit Margin
-8.59%1.30%2.48%12.36%9.39%
Operating Profit Margin
-19.64%-7.24%2.48%23.07%13.74%

All data in USD

Charts